Biotin, Benign Modules, and Final Takeaways
Todd W. Frieze, MD, concludes this series discussing differences in benign vs cancerous tumors and key final takeaways.
Thyroid Hormone Monitoring and Patient Surveillance
Todd W. Frieze, MD, highlights the various ways to accurately assess patient thyroid hormone levels and the general guidelines on patient surveillance.
Suppression Therapy for Hypothyroidism and Risk Stratification
Todd W. Frieze, MD, discusses various suppression therapy approaches for patients with hypothyroidism and thyroid cancer.
An Overview of Thyroid Cancer and Treatment Goals
Todd W. Frieze, MD, discusses the therapeutic role of TSH suppression in differentiated thyroid cancer, as well as treatment goals and ongoing surveillance strategies.
